Hybrid chronic care company Thirty Madison revealed its new dermatology offering, following through on plans its executives spoke with Erin about exclusively back in January.
Why it matters: Thirty Madison has rapidly mushroomed from a digital pharmacy selling medications for hair loss and migraines into a hybrid care company with offerings for more than five chronic conditions.
Flashback: In February, Thirty Madison acquired reproductive health-focused digital pharmacy Nurx.
- The deal more than doubled its number of active patients to 750,000 from 350,000.
- It also boosted Thirty Madison’s B2B presence by giving it access to Nurx’s relationships with pharmacy benefits managers.
- And last fall, Thirty Madison said it would open its first in-person location in New York, a hair transplant clinic under its Keeps brand, this year.
Details: Called Facet, the new vertical offers customers 50-plus prescription and non-prescription treatments and care plans it says are guided by board-certified dermatologists including Peter Young, its newest medical director.
- Facet sells anti-aging treatments as well as medications for eczema, psoriasis, acne, rosacea, dandruff and melasma.
The big question: Can Thirty Madison prove that its direct-to-consumer house of brands strategy is a profitable care model? Only time will tell.What’s next: Thirty Madison told Erin back in January that it planned to launch a new vertical for sleep health, and hired Vik Panda to lead the category as a general manager.